Responses
Original article
Biomarkers and heart disease
Evaluation of novel biomarkers for the diagnosis of acute destabilised heart failure in patients with shortness of breath
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 24 June 2009
- Published on: 24 June 2009MULTI MARKER OR SINGLE MARKER, CLINICAL CORRELATION IS A MUSTShow More
It is known fact that emergency physicians misdiagnose heart failure in about 40% cases and these patients have high mortality rate of around 21%.The novel biomarkers like BNP assay significantly improves the accuracy of diagnosis of acute heart failure in patients presenting to the emergency department with dyspnea. The cut off point of 100 pg/ml, BNP has a sensitivity of 90% in isolation of clinical factors but the speci...
Conflict of Interest:
None declared.